Glycopyrrolate Injection
Product Images NDC 71872-7289

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71872-7289.jpg (71872 7289)

71872-7289.jpg (71872 7289)
This is a description of Glycopyrrolate Injection, USP in a 20 mL Multiple Dose Vial. The solution contains 4 mg/20 mL (0.2mg/mL) and is not recommended for use in newborns due to the presence of benzyl alcohol. It is intended for intramuscular or intravenous administration only. The usual dosage is not specified in this text. It should be stored at the temperature range of 20°C to 25°C (68°F to 77°F). The manufacturer is Amneal Pharmaceuticals in India, and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The lot number and expiration date are also specified. This text also includes the Manufacturer NDC and information about medical purchasing solutions.*
FDA Label Image

Structure (Glycopyrrolate Injection Usp 1)

Structure (Glycopyrrolate Injection Usp 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.